CB-NK-TGF-ßR2-/NR3C1-

· MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CB-NK-TGF-ßR2-/NR3C1-, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM [Phase 1]